Established in 2015, Quark Venture is focused on equity financing of innovative biotechnology and health sciences companies with breakthrough technology platforms and projects.
 
Our strategic goal is to support and enable companies we invest in to grow, create value and be successful by providing not only financial support, but also developmental, infrastructure and expertise support, as needed, through our global network.
 
Our approach is to establish long-term relationships with target companies, with a view to enable and strengthen management to realize the full potential and value of the technology. This approach has previously been successfully demonstrated in the energy and high-tech sectors where Quark Venture partners have invested.
 
While Quark Venture is headquartered in Vancouver, it has offices in Boston, Hong Kong and Chengdu, and plans to establish a European office in 2017.

SQZ Biotech

Biscayne NeuroTherapeutics

Keros Therapeutics

Eloxx

Quark Venture

Recursion is a biotech company focused on drug development and utilizes AI for drug discovery.

Recursion

Jazz Pharmaceuticals is a biopharmaceutical company that develops and commercializes medicines for various medical needs.

Jazz Pharmaceuticals

PTC Therapeutics is a biopharmaceutical company focused on the discovery and development of orally administered small-molecule drugs.

PTC Therapeutics

PureTech Health is a biopharmaceutical company that focuses on developing and commercializing innovative medicines for various diseases.

PureTech Health

Neumora is a biotech company specializing in the development of long-acting oral therapies for mental health disorders.

Neumora

Karuna Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies for neuropsychiatric disorders.

Karuna Therapeutics

AskBio is a biotech company specializing in the development of gene therapies for various genetic disorders and diseases.

AskBio

Acorda is a biopharmaceutical company that develops and commercializes therapies for neurological disorders.

Acorda

Lyndra is a biopharmaceutical company that focuses on the development of long-acting oral therapies. Their proprietary technology platform aims to transform the administration of oral medications, enabling extended-release formulations that can last for a week or more.

Lyndra

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 16, 2024 1:16 PM	b9d7340f
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Oct 31, 2024 9:55 AM	bb937048
crunchbase profile	general
li profile	general	May 16, 2024 1:16 PM	67d67689
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:QUARKVENTURE

Lyndra